Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy

Taku Fujimura; Yumi Kambayashi; Yota Sato; Kayo Tanita; Hisayuki Tono; Chunbing Lyu; Toshiya Takahashi; Akira Hashimoto; Setsuya Aiba

doi:10.1111/1346-8138.14786

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy

Taku Fujimura, Yumi Kambayashi, Yota Sato, Kayo Tanita, Hisayuki Tono, Chunbing Lyu, Toshiya Takahashi, Akira Hashimoto, Setsuya Aiba

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	e260
Journal	Journal of Dermatology
Volume	46
Issue number	7
DOIs	https://doi.org/10.1111/1346-8138.14786
Publication status	Published - 2019 Jul

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/1346-8138.14786

Cite this

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy. / Fujimura, Taku ; Kambayashi, Yumi; Sato, Yota; Tanita, Kayo; Tono, Hisayuki; Lyu, Chunbing; Takahashi, Toshiya ; Hashimoto, Akira; Aiba, Setsuya.

In: Journal of Dermatology, Vol. 46, No. 7, 07.2019, p. e260.

Research output: Contribution to journal › Letter › peer-review

Fujimura, Taku ; Kambayashi, Yumi ; Sato, Yota ; Tanita, Kayo ; Tono, Hisayuki ; Lyu, Chunbing ; Takahashi, Toshiya ; Hashimoto, Akira ; Aiba, Setsuya. / Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy. In: Journal of Dermatology. 2019 ; Vol. 46, No. 7. pp. e260.

@article{173a16f013bf494aa4b5fa4cc6f30091,

title = "Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy",

author = "Taku Fujimura and Yumi Kambayashi and Yota Sato and Kayo Tanita and Hisayuki Tono and Chunbing Lyu and Toshiya Takahashi and Akira Hashimoto and Setsuya Aiba",

year = "2019",

month = jul,

doi = "10.1111/1346-8138.14786",

language = "English",

volume = "46",

pages = "e260",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy

AU - Fujimura, Taku

AU - Kambayashi, Yumi

AU - Sato, Yota

AU - Tanita, Kayo

AU - Tono, Hisayuki

AU - Lyu, Chunbing

AU - Takahashi, Toshiya

AU - Hashimoto, Akira

AU - Aiba, Setsuya

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85060581896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060581896&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.14786

DO - 10.1111/1346-8138.14786

M3 - Letter

C2 - 30672615

AN - SCOPUS:85060581896

VL - 46

SP - e260

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 7

ER -

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this